IPO registrations (S-1, F-1) · Registrants
China BCT Pharmacy Group, Inc.
- SEC CIK
- 1399356 · filings on EDGAR ↗
- Former names
- CHINA BAICAOTANG MEDICINE Ltd (2009–2010); PURDEN LAKE RESOURCE CORP. (2007–2009)
- Registration
- Form S-1, first filed 2010-03-03, last 2011-03-03; 1 initial registration, 12 amendments
- Outcome
- Final prospectus filed 2011-03-22; declared effective 2011-03-17
- Industry (SIC)
- Wholesale-Drugs, Proprietaries & Druggists' Sundries 5122
- Incorporated in
- DE
- Business address
- NO. 102, CHENGZHAN ROAD, LIUZHOU CITY, Guangxi Province, F4 00000
- EIN
- 20-8067060
- EDGAR entity type
- operating
- Insiders and CEO pay
- China BCT Pharmacy Group, Inc. on the corporate pages
Offering terms
- Final price
- $3.81 per share (424B1 filed 2011-03-22)
- Shares sold
- 5,630,575
- Gross proceeds
- $21,452,490 before underwriting discounts and any over-allotment option
- Listing
- OTC under the symbol CNBI
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- SEC filer: CHINA BAICAOTANG MEDICINE Ltd EXACT (CIK (EXACT))
Filings 18
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2010-03-03 | S-1 | S-1 (registration) | CHINA BAICAOTANG MEDICINE Ltd | 0001213900-10-000767 ↗ |
| 2010-05-27 | S-1/A | S-1/A (amendment) | China BCT Pharmacy Group, Inc. | 0001213900-10-002237 ↗ |
| 2010-07-29 | S-1/A | S-1/A (amendment) | China BCT Pharmacy Group, Inc. | 0001213900-10-003011 ↗ |
| 2010-08-31 | S-1/A | S-1/A (amendment) | China BCT Pharmacy Group, Inc. | 0001213900-10-003620 ↗ |
| 2010-09-30 | S-1/A | S-1/A (amendment) | China BCT Pharmacy Group, Inc. | 0001213900-10-003984 ↗ |
| 2010-10-20 | S-1/A | S-1/A (amendment) | China BCT Pharmacy Group, Inc. | 0001213900-10-004261 ↗ |
| 2010-11-16 | S-1/A | S-1/A (amendment) | China BCT Pharmacy Group, Inc. | 0001213900-10-004858 ↗ |
| 2010-12-14 | S-1/A | S-1/A (amendment) | China BCT Pharmacy Group, Inc. | 0001213900-10-005215 ↗ |
| 2011-01-07 | S-1/A | S-1/A (amendment) | China BCT Pharmacy Group, Inc. | 0001213900-11-000077 ↗ |
| 2011-01-25 | S-1/A | S-1/A (amendment) | China BCT Pharmacy Group, Inc. | 0001213900-11-000291 ↗ |
| 2011-02-10 | S-1/A | S-1/A (amendment) | China BCT Pharmacy Group, Inc. | 0001213900-11-000647 ↗ |
| 2011-02-17 | S-1/A | S-1/A (amendment) | China BCT Pharmacy Group, Inc. | 0001213900-11-000875 ↗ |
| 2011-03-03 | S-1/A | S-1/A (amendment) | China BCT Pharmacy Group, Inc. | 0001213900-11-001099 ↗ |
| 2011-03-17 | EFFECT | EFFECT (declared effective) | China BCT Pharmacy Group, Inc. | 9999999995-11-000696 ↗ |
| 2011-03-22 | 424B1 | 424B1 (final prospectus) | China BCT Pharmacy Group, Inc. | 0001213900-11-001461 ↗ |
| 2011-05-12 | EFFECT | EFFECT (declared effective) | China BCT Pharmacy Group, Inc. | 9999999995-11-001503 ↗ |
| 2012-12-28 | EFFECT | EFFECT (declared effective) | China BCT Pharmacy Group, Inc. | 9999999995-12-003672 ↗ |
| 2013-01-03 | 424B1 | 424B1 (final prospectus) | China BCT Pharmacy Group, Inc. | 0001213900-13-000008 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2011-03-03 | S-1/A | registration statement | 3,937 | - | OTC CNBI | 0 | primary document; shares headline | document ↗ | ||
| 2011-03-22 | 424B1 | final prospectus | $3.81 | 5,630,575 | $21,452,490 | OTC CNBI | 0 | primary document; price line, shares headline, proceeds computed | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Zhang Xiaoyan | Director,Officer,TenPercentOwner | CFO; Chief Financial Officer | 3 | 2010–2012 | |
| Choi Hon Keung Simon | Director | 3 | 2010–2012 | ||
| Lee Eng Leong | Director | 2 | 2010 | ||
| Tang Hui Tian | Director,Officer | Chairman and CEO; Chairman & CEO | 3 | 2010–2012 | |
| CHIU MAN WAI JAMES | Director | 3 | 2010–2012 | ||
| Lou Yunli | Director | 1 | 2011 | ||
| Chin Kam-Cheung | Director | 1 | 2012 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| SEC filer | China BCT Pharmacy Group, Inc. | SEC filers (EDGAR) | CIK (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Wholesale-Drugs, Proprietaries & Druggists' Sundries, F4 first:
- CHINA MEDICINE CORP F4
- Global Pharm Holdings Group, Inc. F4
- Dongsheng Pharmaceutical International Co., Ltd. F4
- Mu Yan Technology Group Co., Ltd F4
- FV Pharma International Corp. A6
- Artemis Strategic Investment Corp AZ
- WOMEN FIRST HEALTHCARE INC CA
- China Yongxin Pharmaceuticals Inc. CA
- DAVI LUXURY BRAND GROUP, INC. CA
- Merion, Inc. CA
Interests: Wholesale-Drugs, Proprietaries & Druggists' Sundries